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Background: Anemia is the risk factor for cerebrovascular events. The aim of this study was
to evaluate the prevalence of anemia among patients with ﬁrst-ever stroke and its impact on
neurological state in the acute phase of the disease and the degree of disability in short-term
follow-up.
Patients and methods: The prospective study included 107 patients aged 72.81  11.12 with
the ﬁrst-ever stroke. Each patient underwent CT of the head and blood tests, including Hb
concentration on the ﬁrst day of hospitalization. We have analyzed the neurological state on
the ﬁrst day of stroke by NIHSS and the functional status on the 14th day after the onset of
stroke by mRankin scale in patients with and without anemia. Patients with anemia were
additionally divided according to Hb level (less or over 11 g/dl).
Results: Patients with Hb ≤ 11 g/dl signiﬁcantly more often achieved a score of 4–5 points on
mRankin scale on the 14th day of stroke compared to patients with anemia and Hb > 11 g/dl.
Independent predictors of a worse functional status on the 14th day of stroke in patients
with anemia include the neurological state on the 1st day and the hemispheric location of
stroke; an independent predictor of death was the neurological state on the 1st day of onset.
Conclusion: Mild anemia did not inﬂuence signiﬁcantly the neurological condition in acute
phase of stroke but worsened the functional status in subacute phase of stroke.
The neurological state on the ﬁrst day of stroke and the hemispheric location of cerebral
ischemia are independent factors of poor prognosis in patients with anemia in short-term
follow-up.
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Anemia is the most common hematologic disorder which
incidence increases with the patient's age. It is a risk factor for
cardiovascular events, including cerebrovascular ones. Ane-
mia is associated with increased disability and mortality.
However, it is considered an independent risk factor for stroke
in children; children's anemia has been observed in more than
half of the cases without the presence of other risk factors for
stroke [1–5]. The relationship between the entire range of low
hemoglobin concentrations and the outcome after stroke in
adults is ambiguous. Whereas hypertension, diabetes, smok-
ing habit, old age and dyslipidemia are well-known vascular
risk factors for stroke, the role of hemoglobin (Hb) value is still
up for debate [6]. In 1972, the Framingham Study conducted on
more than 5000 patients concluded that the pathogenetic,
preventive and therapeutic implications of the interrelation-
ship between hemoglobin level and stroke would have
required further exploration [7]. Close attention is paid to
the relationship between stroke and anemia in patients with
sickle cell anemia. Emphasis has been put on the importance
of genetic and molecular factors underlying nerve structure
ischemia in this patient group [8]. It has been observed that in
subjects without primary hematologic disorders anemia has a
negative impact on the course of stroke, especially hemor-
rhagic one, and its prognosis. Disorders of oxygen distribution
to the neural tissue induce hypoxia in the brain region affected
by impaired blood ﬂow. Independently from the traditional
risk factors for stroke, thrombocytosis secondary to iron
deﬁciency may be an additional factor causing deterioration in
blood supply to the brain.
Recently published studies found a relationship between
anemia during stroke and the size of infarct territory, over
1-year mortality and worse long-term outcomes [9–11]. To
date, no studies have been conducted in relation to the effect
of anemia on the course of the acute phase of stroke and
prognosis in the short-term follow-up in adults.
The aim of this study was to evaluate the prevalence of
anemia among patients with ﬁrst ever stroke and its impact on
their neurological state in the acute phase of the disease and
the degree of disability in short-term follow-up.
2. Patients and methods
The prospective study conducted between November 2012 and
February 2013 included 107 patients aged 72.81  11.12
(median 75, min 29, max 92) on the ﬁrst day of the patient's
ﬁrst-ever ischemic stroke diagnosed according to the WHO
criteria and based on radiological images (computed tomog-
raphy (CT) and/or magnetic resonance (MRI) of the head) [12].
All patients were hospitalized during the acute phase of stroke
in the Department of Neurology of the Academic Medical
Center, where diagnostics and therapy were conducted in
accordance with the current guidelines [13,14]. Ethical com-
mittee approval was not required because the study was based
on a routine laboratory tests performed in every patients with
a stroke – no patient identiﬁcation was recorded and thus the
study did not fulﬁll the criterion of a medical experiment.Each patient was interviewed and underwent physical
examination, CT of the head and blood tests, including Hb
concentration on the ﬁrst day of hospitalization.
On the basis of the existing patients' records and
examination results, the presence of comorbidities generally
recognized as certain and probable risk factors for stroke was
found during hospitalization.
The following criteria were used to diagnose the selected
comorbidities:
 Arterial hypertension – patient diagnosed or treated for
arterial hypertension before the stroke or the in-hospital
blood pressure values were above 140/90 mmHg.
 Diabetes – patient diagnosed or treated for diabetes before
the stroke, any in-hospital glycemia was above 200 mg/dl,
fasting plasma glucose measured on 2 different days was
above 126 mg/dl or the 2-h oral glucose tolerance test (OGTT)
glucose was above 200 mg/dl.
 Coronary artery disease – diagnosis made before the
hospitalization, history of typical symptoms (including
relatives), typical ECG changes (prior myocardial infarction,
ischemic abnormalities in ECG) or typical echocardiographic
ﬁndings (regional wall motion abnormality, lowered ejection
fraction).
 Atrial ﬁbrillation or ﬂutter – arrhythmias documented earlier
or present in ECG during the present hospitalization.
 Lipid disorder – LDL level >130 mg/dl in patients without
ischemic heart disease or >100 mg/dl in patients with
coronary artery disease or triglyceride level >150 mg/dl or
patient already treated for hyperlipidemia (statins, ﬁbrates,
ezetimibe).
 Myocardial infarction – increase in TnI on the second day
of stroke by at least 25% in relation to the baseline assay,
CK-MB > 25 UI (on the 1st day of stroke), ST-T elevation or
depression in the ECG ≥ 0.1 mV or formation of a new
pathological Q-wave.
 Heart failure–was recognized as a clinical syndrome charac-
terized by speciﬁc symptoms (dyspnea and fatigue) in the
medical history and signs (edema, rales) on the physical
examination.
The above-mentioned conditions were conﬁrmed by a
cardiologist or internal medicine specialist.
The following deﬁnitions of anemia were applied: Hb serum
level <13.5 g/dl in men and <12 g/dl in women [15]. The
incidence of anemia was examined in the entire group of
patients, then the subjects were divided by sex and age (≤ and
>65 years)
The following parameters were compared between in
patients with anemia (Group 1) and in patients with normal
hemoglobin serum level (Group 2): neurological state on the
ﬁrst day of stroke (by National Institute Health Stroke Scale,
NIHSS), the functional status on the 14th day after the onset of
stroke (by mRankin scale, mRS) and death incidence within a
month after stroke, and the incidence of selected comorbid-
ities and biochemical parameters.
The analysis of the neurological state on the 1st day of
stroke (NIHSS) in both groups has also included, the
differentiation between a ‘‘slight’’ (NIHSS 0–4) and moder-
ate/severe (NIHSS > 4) neurological deﬁcit.
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according to Hb serum level (Hb ≤ and >11 g/dl). The following
parameters were compared between selected subgroups: state
according to NIHSS, the functional status (mRS) on the 14th
day and death incidence within a month after stroke.
The statistical analysis was performed by the means of
Statistica 5.0 software. For the comparison of the nonpara-
metric values the Chi2 test and U Mann–Whitney test were
used. Parametric data analysis was based on the t-Student test
and p value of <0.05 was considered as a statistically
signiﬁcant.
Logistic regression analysis was performed in order to
determine independent factors of worse prognosis (acc. to
mRS, a state of 3–5 and death) among analyzed patients.
Analysis concerned the importance of the following factors:
gender, age, arterial hypertension, diabetes, ischemic heart
disease, lipid disorders, heart failure, atrial ﬁbrillation, stroke
location (hemisphere or brainstem).
3. Results
Anemia was diagnosed in 15 women (28.30%) and 17 men
(31.48%), in 8 patients (26.67%) aged ≤65 years and in 24
(31.17%) patients >65 years. Differences in the prevalence of
anemia by gender and age were not statistically signiﬁcant;
p = 0.71 and 0.64, respectively. In women aged >65 years
anemia occurred more frequently than in younger women
(29.72% vs 25% respectively; p = 0.77). Similarly, in men >65Table 1 – The characteristics of patients from Group 1 and Gro
Patients with anemia n = 32 
Sex (F) 15 (46.9%) 
Age 74.47  10.58
Mediana 78
Min 54 max 89
Hemispheric location 22 (68.8%) 
Thrombolytic therapy 1 (3.1%) 
Na+ 138.33  4.11 
K+ 4.03  0.41 
eGFR 58.59  26.14 
CrCl 1.28  0.67 
NIHSS 5.47  4.88
Mediana 3.50
Min 0 max 16
mRS 2.78  1.96
Mediana 3
Min 0 max 6
mRS 3–5 16 (50%) 
Mortality 2 (6.3%) 
AH 27 (84.4%) 
DM 15 (46.9%) 
AF 12 (37.5%) 
LD 2 (6.3%) 
HF 22 (68.8%) 
Past MI 1 (3.1%) 
eGFR – estimated glomerular ﬁltration rate, CrCl – creatinine clearance,
Rankin scale, AH – arterial hypertension, DM – diabetes mellitus, AF – at
a t-Student's test.
b U Mann–Whitney test.years anemia occurred more frequently (33.33%) than in the
younger age group (27.78%, p = 0.67).
The causes of anemia are presented in Table 2.
Among patients with anemia (Group 1) type 2 diabetes and
abnormal renal parameters (creatinine and/or estimate
glomerular ﬁltration rate, eGFR) were signiﬁcantly more
common; however, lipid disorders and past myocardial
infarction were observed signiﬁcantly more often in patients
without anemia (Group 2). The incidence of other parameters
selected for the analysis in Groups 1 and 2 showed no
statistically signiﬁcant differences.
The characteristics of patients with anemia and normal
hemoglobin level are shown in Table 1.
The mean serum concentration of hemoglobin among
patients with anemia was 11.08 g/dl  1.12 (median 1.22, min
8.37, max 12.86).
The mean serum concentration of hemoglobin in women
was: 13.00 g/dl  1.73 (median 13.14, min 8.37, max 17.47).
The mean serum concentration of hemoglobin in men was:
13.65 g/dl  2.02 (median 14.06, min 8.61, max 18.18).
There were no signiﬁcant differences in neurological deﬁcit
on 1st day (NIHSS), functional status at the level of 3–5 (mRS)
on 14th day and death within ﬁrst month between analyzed
groups (1 vs 2) (Tables 3 and 4).
Patients with Hb ≤ 11 g/dl signiﬁcantly more often achieved
a score of 4–5 points on mRankin scale on the 14th day of
stroke compared to patients with anemia and Hb > 11 g/dl
( p = 0.0167). There were no statistically signiﬁcant differences
in the neurological state according to NIHSS (p = 0.0979) and inup 2.
Patients without anemia n = 75 p (Chi2)
38 (50.7%) 0.7195
71.16  11.66
Mediana 72
Min 29 max 92
0.1703a
47 (62.7%) 0.5472
8 (10.7%) 0.1982
138.09  3.81 0.7764a
3.95  0.48 0.3910a
71.95  16.11 0.0227b
0.93  0.24 0.0002a
4.96  4.83
Mediana 3
Min 0 max 18
0.5059b
2.37  1.94
Mediana 2
Min 0 max 6
0.3148b
33 (44%) 0.5684
3 (4.0%) 0.6136
68 (90.7%) 0.3450
19 (25.3%) 0.0284
22 (29.3%) 0.4062
17 (22.7%) 0.0419
44 (58.7%) 0.3260
16 (21.3%) 0.0183
 NIHSS – National Institutes of Health Stroke Scale, mRS – modiﬁed
rial ﬁbrillation, LD – lipid disorders, HF – heart failure
Table 6 – The risk of functioning state at level 3–5 points
in mRS and death in patients without anemia.
Risk factor for
3–5 mRS
p (model) p (factor) RR
NIHSS 0.0001 0.0068 1.19
95% CI
[1.05–1.35]
Risk factor for death p (model) p (factor) RR
NIHSS 0.0095 0.00292 1.33
95% CI
[1.02–1.73]
NIHSS – National Institutes of Health Stroke Scale.
The following co-variables were analyzed: sex, age, NIHSS, arterial
hypertension, diabetes, lipid disorders, atrial ﬁbrillation, coronary
heart disease, heart failure, past myocardial infarct, Na+, K+,
estimated glomerular ﬁltration rate, creatinine clearance.
Table 4 – The functioning state according to mRS in
Groups 1 and 2.
Patients with
anemia n = 32
Patients without
anemia n = 75
p
mRS 0–2 14 (43.75%) 39 (52%) 0.4345
mRS 3–5 16 (50%) 33 (44%) 0.5684
mRS 6 2 (6.25%) 3 (4%) 0.6136
mRS – modiﬁed Rankin scale.
Table 3 – The neurological state according to NIHSS in
Groups 1 and 2.
Patients with
anemia n = 32
Patients without
anemia n = 75
p
NIHSS 0–4 18 (56.25%) 48 (64%) 0.4503
NIHSS >5 14 (43.75%) 27 (36%)
NIHSS – National Institutes of Health Stroke Scale.
Table 2 – Causes of anemia.
Cause of anemia n (%)
Chronic urinary tract infection 3 (9.37)
Neoplasmatic disease 3 (9.37)
Rheumatoid arthritis 1 (3.12)
Iron insufﬁciency 19 (59.37)
Postbleeding anemia 1 (3.12)
Undeﬁned 5 (15.62)
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(p = 0.1931).
Independent predictors of a worse functional status
(3–5 points by mRankin) on the 14th day of stroke among
patients with anemia include the neurological state on the 1st
day of stroke (NIHSS) and the hemispheric location of stroke;
an independent predictor of death was the neurological state
on the 1st day of onset (Table 5).Table 5 – The risk of functioning state at level 3–5 points
in mRS and death in patients with anemia.
Risk factor
for 3–5 mRS
p (model) p (factor) RR
Hemispheric location 0.0000 0.0132 3.37
95% CI
[1.27–8.92]
NIHSS 0.0003 1.23
95% CI
[1.10–1.37]
Risk factor for death p (model) p (factor) RR
NIHSS 0.0004 0.024 1.28
95% CI
[1.03–1.59]
mRS – modiﬁed Rankin Scale, NIHSS – National Institutes of Health
Stroke Scale.
The following co-variables were analyzed: sex, age, NIHSS, arterial
hypertension, diabetes, lipid disorders, atrial ﬁbrillation, coronary
heart disease, heart failure, past myocardial infarct, Na+, K+,
estimated glomerular ﬁltration rate, creatinine clearance.The neurological condition on the ﬁrst day of onset was
recognized as an independent predictor of a worse functional
status (3–5 points by mRankin or death) among the patients
with normal serum hemoglobin level (Table 6).
4. Discussion
Anemia accompanies cardiovascular diseases and is associat-
ed with the occurrence of cerebrovascular events [16–18]. It has
been shown that anemia inﬂuences increased mortality,
disability, susceptibility to falls and intellectual deﬁcit in the
elderly, and acute cerebral ischemia in children [19–24]. It was
found that in patients with hemorrhagic stroke low hemoglo-
bin concentration at admission and Hb nadir in the acute
phase of disease are independent predictors of neurological
deﬁcit [25,26]. Association of anemia and the size of hemor-
rhagic focus in brain structures has been previously conﬁrmed
[27,28].
Except for patients with sickle cell anemia, the importance
of anemia for cerebral ischemia in adults has not been
deﬁnitely established. It is believed that the physiological
regulation of cerebral blood ﬂow should meet the brain's
demand for oxygen in pathological state, including profound
anemia. Given the incidence of both stroke and anemia in the
population, the problem of a possible cause-and-effect
relationship or the inﬂuence of anemia on the course of
stroke in adults is relatively rarely discussed, especially in
relation to ischemic stroke.
In the present study anemia was recognized in almost 30%
of patients with ischemic stroke, particularly in subjects >65
years of age. No signiﬁcant relationship was found between
anemia and the subjects' gender. Tanne et al. observed a
reverse correlation between hemoglobin concentration and
age [29]. Dubyk et al. found that among patients with ﬁrst-ever
stroke or transient ischemic attack (TIA) in patients >65 years
anemia occurs more often than established in the population
registers (NHANESS III) [30]. In the current study, anemia was
found signiﬁcantly more often in patients with abnormal renal
parameters and diabetes.
In the present study, anemia was associated with a worse
neurological state on the 1st day of stroke and a more serious
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14th day after stroke. However, as compared to subjects with
normal Hb concentration, the differences were not statistically
signiﬁcant.
The neurological state on the 1st day of stroke and stroke
location in the brain hemisphere. turned out to be an
independent factors of a worse prognosis in the short-term
follow-up after stroke in patients with anemia like age, the
patients' state by NIHSS is a signiﬁcant predictor of disability
and death during hospitalization of patients with cerebral
stroke [26,31]. The other known factors affecting the patients
in the acute phase of stroke and inﬂuencing prognosis
include the time of therapy inclusion, the vascular territories
involved, arterial pressure, blood glucose concentration and
body temperature [32]. They may negatively impact the
cerebral circulation, decreasing oxygen-carrying capacity
and promoting rapid deterioration of ischemic penumbra.
Anemia may induce a hyperkinetic circulatory state and
upregulate the endothelial adhesion molecule genes, which
may lead to thrombus generation [33]. Furthermore, blood
ﬂow augmentation and turbulence may result in the
migration of a thrombus that had already existed in the
diseased vessel, thus producing artery-to-artery embolism
[33].
The negative impact of anemia on the course of stroke and
the outcome after stroke was observed by other investigators
[34–36]. However, the authors presented the results of long-
term follow-ups.
In the present study in patients with anemia, as compared
to those with normal hemoglobin concentration, there were
no signiﬁcant differences in the neurological state and
functioning in the acute phase of stroke. Additionally,
anemia did not cause a signiﬁcantly higher mortality rate.
Such a relationship has been already proven in the short and
long-term follow-up but in patients with coronary heart
disease [16,17]. However, it should be noted that in the
present study the mean concentration of hemoglobin in
patients with anemia was above 10 g/dl. It is likely that
within the patients' level of anemia the mechanisms
which compensate for the negative impact of anemia in
the acute period of stroke were efﬁcient. I Interestingly,
anemia was proved to be a risk factor for death. A
mathematical modeling study in rabbit's brain found that
penumbral extraction reserve was nearly exhausted at a
hemoglobin concentration of approximately 10 g/dl and
oxygen uptake in the ischemic penumbra decreased pro-
gressively when hemoglobin concentration further
decreases. Therefore, a hemoglobin concentration of 10 g/
dl might represent the rational transfusion ‘‘trigger’’ for the
acutely anemic stroke patients, although a suitable random-
ized clinical study has to be performed before validation of
the proposed model [37].
The evaluation of hemoglobin concentration allows to
identify those patients who may suffer from the more serious
consequences of stroke. Further studies are required in
patients with anemia in the acute phase of stroke in order
to better understand the importance of anemia in that period
and the pathophysiological relevance of abnormal morpholo-
gy parameters and other factors active in the acute period of
cerebral ischemia.5. Limitations
The study has some limitations, the main was the lack of
analysis related to the impact of the condition before stroke on
the degree of post-stroke disability.
6. Conclusion
Mild anemia did not inﬂuence signiﬁcantly the neurological
condition in acute phase of stroke but worsened the functional
status in subacute phase of stroke.
The neurological state on the ﬁrst day of stroke and the
hemispheric location of cerebral ischemia are independent
factors of bad prognosis in patients with anemia in short-term
follow-up.
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